Suppr超能文献

使用(68)镓气雾剂(镓气体)和(68)镓标记的大颗粒白蛋白进行PET肺通气/灌注成像。

PET lung ventilation/perfusion imaging using (68)Ga aerosol (Galligas) and (68)Ga-labeled macroaggregated albumin.

作者信息

Ament S J, Maus S, Reber H, Buchholz H G, Bausbacher N, Brochhausen C, Graf F, Miederer M, Schreckenberger M

机构信息

Department of Nuclear Medicine, University Medical Centre, Johannes Gutenberg-University, Mainz, Germany.

出版信息

Recent Results Cancer Res. 2013;194:395-423. doi: 10.1007/978-3-642-27994-2_22.

Abstract

Pulmonary imaging using ventilation/perfusion (V/P) single-photon emission tomography (V/P scan) with Tc-99m-labeled radiotracers is a well-established diagnostic tool for clinically suspected pulmonary embolism (PE). Ga-68 aerosol (Galligas) and Ga-68-labeled macroaggregated albumin (MAA) are potential tracers for positron emission tomography (PET) lung V/P imaging and could display an advantage over conventional V/P scans in terms of sensitivity and specificity. After radiochemical and animal studies, the clinical applicability of Ga-68 aerosol (Galligas) and Ga-68-labeled MAA was investigated in an exploratory study in patients with clinical suspicion of PE. PET scans were acquired using a 16-slice Gemini TF positron emission tomography/computed tomography (PET/CT) scanner. The acquisition protocol included low-dose computed tomography (CT) for attenuation correction (AC). Dosimetry calculations and continuative phantom measurements were performed. Structural analyses showed no modification of the particles due to the labeling process. In addition, in vitro experiments showed stability of Ga-68 MAA in various media. As expected, Ga-68-labeled human serum albumin microspheres (HSAM) were completely retained in the lung of the animals. In clinical use, PET lung ventilation and perfusion imaging using Ga-68 aerosol (Galligas) and Ga-68-labeled MAA was successful in all cases. In one case a clinically suspected PE could be detected and verified. The administered activity of Ga-68 aerosol (Galligas) and Ga-68-labeled MAA may be reduced by more than 50%, resulting in comparable radiation exposure to conventional V/P scans. In conclusion, Ga-68 aerosol (Galligas) and Ga-68-labeled MAA are efficient substitutes for clinical use and could be an interesting alternative with high accuracy for lung V/P imaging with Tc-99m-labeled radiotracers, especially in times of Mo-99 shortages and increasing use and spread of PET/CT scanners and Ga-68 generators, respectively.

摘要

使用锝-99m标记的放射性示踪剂进行通气/灌注(V/P)单光子发射断层扫描(V/P扫描)的肺部成像,是临床上疑似肺栓塞(PE)的一种成熟诊断工具。镓-68气雾剂(Galligas)和镓-68标记的聚合白蛋白(MAA)是正电子发射断层扫描(PET)肺部V/P成像的潜在示踪剂,在灵敏度和特异性方面可能比传统V/P扫描具有优势。经过放射化学和动物研究后,在一项针对临床疑似PE患者的探索性研究中,对镓-68气雾剂(Galligas)和镓-68标记的MAA的临床适用性进行了研究。使用16层Gemini TF正电子发射断层扫描/计算机断层扫描(PET/CT)扫描仪进行PET扫描。采集方案包括用于衰减校正(AC)的低剂量计算机断层扫描(CT)。进行了剂量学计算和连续体模测量。结构分析表明,标记过程未导致颗粒发生改变。此外,体外实验表明镓-68 MAA在各种介质中均具有稳定性。正如预期的那样,镓-68标记的人血清白蛋白微球(HSAM)完全滞留在动物肺部。在临床应用中,使用镓-68气雾剂(Galligas)和镓-68标记的MAA进行PET肺部通气和灌注成像在所有病例中均获得成功。在1例病例中,检测并证实了临床疑似的PE。镓-68气雾剂(Galligas)和镓-68标记的MAA的给药活度可降低50%以上,从而使辐射暴露与传统V/P扫描相当。总之,镓-68气雾剂(Galligas)和镓-68标记的MAA是临床应用的有效替代品,对于使用锝-99m标记的放射性示踪剂进行肺部V/P成像而言,可能是一种具有高精度的有趣替代方法,尤其是在钼-99短缺以及PET/CT扫描仪和镓-68发生器的使用和普及不断增加的时期。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验